Publications (84) Publications in which a researcher has participated

filter_list

2025

  1. Assessing early therapeutic drug monitoring of adalimumab as a predictor of treatment efficacy and immunogenicity in rheumatic diseases: “early therapeutic drug monitoring of adalimumab”

    Clinical Rheumatology, Vol. 44, Núm. 3, pp. 1009-1018

  2. Comparative evaluation of point of care assay with ELISA techniques for quantifying serum concentrations of ustekinumab in inflammatory bowel disease patients

    Gastroenterologia y Hepatologia, Vol. 48, Núm. 6

  3. Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic Drug Monitoring of Infliximab and Adalimumab

    Therapeutic Drug Monitoring, Vol. 47, Núm. 3, pp. 346-352

  4. Exploring infliximab serum level variability in inflammatory bowel disease: Comprehensive analysis of patient subgroups and treatment outcomes

    Gastroenterologia y Hepatologia

  5. Exploring the voice of patients: Mapping their experience following care in an integrated health area

    Journal of Healthcare Quality Research

  6. Exploring the voice of patients: Mapping their experience following care in an integrated health area

    Journal of Healthcare Quality Research, Vol. 40, Núm. 3

  7. External Evaluation of Population Pharmacokinetic Models of Ustekinumab in Patients with Inflammatory Bowel Disease

    Therapeutic Drug Monitoring

  8. Impact of ustekinumab exposure on clinical outcomes during induction in inflammatory bowel disease

    Revista Espanola de Enfermedades Digestivas, Vol. 117, Núm. 4, pp. 205-212

  9. Perception of primary care professionals about the frequency with which are carried out «do not do interventions»

    Journal of Healthcare Quality Research, Vol. 40, Núm. 2, pp. 89-96

  10. Psychometric properties of the Mini-Balance Evaluation Systems Test (Mini-BESTest) among multiple populations: a COSMIN systematic review and meta-analysis

    Disability and Rehabilitation

  11. The Healthcare Profession as a Determinant of Depression, Suicidal Ideation, and Drug Use in Spain During the COVID-19 Pandemic Crisis

    Journal of Psychoactive Drugs

  12. The balance evaluation systems test (BESTest), mini-BESTest and brief-BESTest as clinical tools to assess balance control across different populations: A reliability generalization meta-analysis

    PLoS ONE, Vol. 20, Núm. 4

2024

  1. Big cannabis

    Determinantes comerciales de salud, trastornos adictivos y otros problemas (Sociedad Española de Expertos en Tabaquismo (SEDET)), pp. 102-125

  2. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 6, pp. 553-561

  3. Consumo de alcohol, tabaco y cannabis en profesionales sanitarios en España durante la fase pandémica aguda de COVID-19

    Global Health Promotion

  4. Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease

    European Journal of Hospital Pharmacy

2023

  1. Changes in tobacco and e-cigarette consumption in Spanish university students during the COVID-19 lockdown: Identification of vulnerable groups

    Tobacco Induced Diseases, Vol. 21

  2. Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 7, pp. 504-511

  3. Programa piloto de cribado de riesgo cardiovascular en la mujer perimenopáusica desde la farmacia comunitaria: proyecto ‘MENOVASC’

    Farmacéuticos comunitarios, Vol. 15, Núm. 3, pp. 17-24

  4. Taller formativo en consejo sanitario a estudiantes de Fisioterapia y Odontología para promover estilos de vida saludables

    El contexto universitario como espacio promotor de hábitos saludables